User profiles for C. Pinto
candida pintoIcahn school of medicine at mount sinai Verified email at icahn.mssm.edu Cited by 600 |
Post‐acute COVID‐19 syndrome (PCS) and health‐related quality of life (HRQoL)—A systematic review and meta‐analysis
… (C) Forest plot of pooled prevalence of usual activity in EQ-5D-5L questionnaire in post-COVID-19
patients. (D) Forest plot of pooled prevalence of pain/discomfort in EQ-5D-5L …
patients. (D) Forest plot of pooled prevalence of pain/discomfort in EQ-5D-5L …
The Araçuaı-West-Congo Orogen in Brazil: an overview of a confined orogen formed during Gondwanaland assembly
…, CM Noce, CM Wiedemann, CP Pinto - Precambrian …, 2001 - Elsevier
The Neoproterozoic Adamastor-Brazilide Ocean was generated during the breakup of the
Rodinia supercontinent, and remnants of its oceanic lithosphere have been found in the …
Rodinia supercontinent, and remnants of its oceanic lithosphere have been found in the …
[HTML][HTML] Fundão tailings dam failures: the environment tragedy of the largest technological disaster of Brazilian mining in global context
…, MP de Souza Miranda, CEF Pinto - Perspectives in ecology …, 2017 - Elsevier
… (C) Embankment of the dam displaced axis in the critical limit of contact between sandy
tailings and sludge (orange line), 2015 image. Adapted from Google Earth Pro. …
tailings and sludge (orange line), 2015 image. Adapted from Google Earth Pro. …
[HTML][HTML] COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets
…, L Pan, D Pant, C Pe'Er, J Pfiffner-Borges, CJ Pinto… - Nature, 2021 - nature.com
COVID-19, which is caused by SARS-CoV-2, can result in acute respiratory distress syndrome
and multiple organ failure 1 , 2 , 3 – 4 , but little is known about its pathophysiology. Here …
and multiple organ failure 1 , 2 , 3 – 4 , but little is known about its pathophysiology. Here …
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
…, K Numata, B Parsons, AS Paulson, C Pinto… - The Lancet …, 2018 - thelancet.com
… B virus or hepatitis C virus, 12 (57%) of 21 participants who were infected with hepatitis B
virus, and ten (39%) of 26 participants who were infected with hepatitis C virus (figure 5). …
virus, and ten (39%) of 26 participants who were infected with hepatitis C virus (figure 5). …
[PDF][PDF] Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 …
C Aschele, L Cionini, S Lonardi, C Pinto, S Cordio… - J Clin Oncol, 2011 - academia.edu
… A B S T R A C T … Certain relationships marked with a “U” are those for which no
compensation was received; those relationships marked with a “C” were compensated. For …
compensation was received; those relationships marked with a “C” were compensated. For …
Performance of the ALEPH detector at LEP
…, S Natali, V Negro, S Nuzzo, M Papagni, C Pinto… - Nuclear Instruments and …, 1995 - Elsevier
The performance of the ALEPH detector at the LEP e + e − collider is reviewed. The accuracy
of the tracking detectors to measure the impact parameter and momentum of charged …
of the tracking detectors to measure the impact parameter and momentum of charged …
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes
… , which recognize the HLA-C group 1-related alleles … -C Asn80 ), KIR2DL1, which recognizes
the HLA-C group 2-related alleles characterized by a lysine residue at position 80 (HLA-C …
the HLA-C group 2-related alleles characterized by a lysine residue at position 80 (HLA-C …
[HTML][HTML] Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study
…, C Delmege, R Ellis, J Evans, T Everett, CF Pinto… - The Lancet, 2019 - thelancet.com
Background Fetal structural anomalies, which are detected by ultrasonography, have a
range of genetic causes, including chromosomal aneuploidy, copy number variations (CNVs; …
range of genetic causes, including chromosomal aneuploidy, copy number variations (CNVs; …
[HTML][HTML] Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma …
Background: The purpose of this phase II study was to evaluate the efficacy and safety of
cetuximab combined with FOLFIRI as a first-line treatment of advanced gastric or …
cetuximab combined with FOLFIRI as a first-line treatment of advanced gastric or …